AbbVie will expand its medical device manufacturing facility in Ballytivnan, Sligo, Ireland. The company's manufacturing site in Ballytivnan currently produces drug delivery devices, including a pen-style injector that is used in AbbVie products for a range of auto-immune conditions. The site is AbbVie's center of excellence' for medical device manufacture, precision engineering, plastics molding and metrology (the theoretical and practical aspects of measurement).

Over the next four years AbbVie plans to create 50 new jobs focused on devices that deliver AbbVie's medicines. The investment is supported by the Industrial Development Authority (IDA) of Ireland. AbbVie is partnering with the Institute of Technology, Sligo, which is establishing a new medical device-focused education program on its Sligo campus

Since 2013, including this investment, AbbVie has invested EUR 134 million ($150 million) in Ireland, which includes investment in Ballytivnan and broader manufacturing operations in the country. AbbVie employs more than 500 people at five different sites around the country, including three manufacturing plants, two in Sligo and one in Cork. Each of the sites manufactures portions of AbbVie's top 20 products. The company's global manufacturing network includes 13 sites across the United States, Europe, Asia and Puerto Rico,

Source: AbbVie